Neonatal screening strategy for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis.

Samankaltaisia teoksia

• Neonatal screening for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis: four years' experience.
  Tekijä: Ranieri, E., et al.
  Julkaistu: (1994)
• Markedly elevated neonatal immunoreactive trypsinogen levels in the absence of cystic fibrosis gene mutations is not an indication for further testing
  Tekijä: Massie, J, et al.
  Julkaistu: (2006)
• False positive results with immunoreactive trypsinogen screening for cystic fibrosis owing to trisomy 13.
  Tekijä: Priest, F J, et al.
  Julkaistu: (1991)
• Cystic Fibrosis Newborn Screening: Distribution of Blood Immunoreactive Trypsinogen Concentrations in Hypertrypsinemic Neonates
  Tekijä: Paracchini, Valentina, et al.
  Julkaistu: (2011)
• Immunoreactive trypsinogen levels in newborn screened infants with an inconclusive diagnosis of cystic fibrosis
  Tekijä: Ooi, Chee Y., et al.
  Julkaistu: (2019)